XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Liquidity, Going Concern and Management Plans (Details)
$ / shares in Units, $ in Thousands, € in Millions
 1 Months Ended 12 Months Ended
Feb. 02, 2021
USD ($)
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
EUR (€)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations   $ 376,080   $ 343,226 $ 376,080 $ 136,221 $ 7,624
Working capital deficit       26,100      
Accumulated deficit   (1,009,293)   (1,558,088) (1,009,293)    
Net loss from continuing operations       (425,045) (351,786) (599,392)  
Proceeds from convertible debt net       0 389,446 3,003  
Business acquisition, shares issued       0 $ 0 $ 12,395  
Molotov SAS              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Business combination, consideration transferred   115,000 € 101.7        
Business acquisition, shares issued   $ 16,300 € 14.4        
Business acquisition, shares issued (in shares) | shares   5,700,000 5,700,000        
Sales Agreement              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Proceeds from issuance of common stock       292,100      
Deduction of commission and expenses       $ 6,600      
Sale of stock (in shares) | shares       50,620,577      
Weighted average gross sale price per share (in dollars per share) | $ / shares       $ 5.90      
2026 Convertible Notes              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Debt instrument, face amount $ 402,500            
Debt interest rate 3.25%            
Proceeds from convertible debt net $ 389,400            
Payment of financing and stock issuance costs $ 13,100